Jiangsu Kanion Pharmaceutical Co.,Ltd. (SHA:600557)

China flag China · Delayed Price · Currency is CNY
13.78
-0.35 (-2.48%)
Jun 6, 2025, 3:00 PM CST
-21.39%
Market Cap 7.80B
Revenue (ttm) 3.42B
Net Income (ttm) 339.94M
Shares Out 566.16M
EPS (ttm) 0.58
PE Ratio 23.72
Forward PE 16.70
Dividend n/a
Ex-Dividend Date n/a
Volume 18,026,697
Average Volume 10,349,938
Open 14.20
Previous Close 14.13
Day's Range 13.77 - 14.24
52-Week Range 11.77 - 17.57
Beta 0.53
RSI 62.73
Earnings Date Jul 25, 2025

About SHA:600557

Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services. Jiangsu Kanion Pharmaceutical Co.,Ltd. was founded in 1975 and is based in Lianyungang, China. [Read more]

Sector Healthcare
Founded 1975
Employees 6,132
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600557
Full Company Profile

Financial Performance

In 2024, SHA:600557's revenue was 3.90 billion, a decrease of -19.86% compared to the previous year's 4.86 billion. Earnings were 391.86 million, a decrease of -15.58%.

Financial Statements

News

There is no news available yet.